| Type: | Package |
| Title: | Diagnosis of Metabolic Dysfunction Associated Fatty Liver Disease |
| Version: | 3.0.0 |
| Description: | The latest guidelines proposed by International Expert Consensus are used for the clinical diagnosis of Metabolic Associated Fatty Liver Disease (MAFLD). The new definition takes hepatic steatosis (determined by elastography or histology or biomarker-based fatty liver index) as a major criterion. In addition, race, gender, body mass index (BMI), waist circumference (WC), fasting plasma glucose (FPG), systolic blood pressure (SBP), diastolic blood pressure (DBP), triglycerides (TG), high-density lipoprotein cholesterol (HDLC), homeostatic model assessment of insulin resistance (HOMAIR), high sensitive c-reactive protein (HsCRP) for the diagnosis of MAFLD. Each parameter has to be interpreted based on the proposed cut-offs, making the diagnosis slightly complex and error-prone. This package is developed by incorporating the latest international expert consensus guidelines, and it will aid in the easy and quick diagnosis of MAFLD based on FibroScan in busy healthcare settings and also for research purposes. The new definition for MAFLD as per the International Consensus Statement is described by Eslam M et al (2020). <doi:10.1016/j.jhep.2020.03.039>. |
| License: | GPL (≥ 3) |
| Encoding: | UTF-8 |
| LazyData: | true |
| RoxygenNote: | 7.3.2 |
| URL: | https://github.com/jagadishramasamy/mafld |
| BugReports: | https://github.com/jagadishramasamy/mafld/issues |
| Suggests: | knitr, rmarkdown, testthat |
| Imports: | dplyr |
| Depends: | R (≥ 3.5.0) |
| NeedsCompilation: | no |
| Packaged: | 2025-09-09 15:43:27 UTC; jagadish |
| Author: | Jagadish Ramasamy 
[aut, cre] |
| Maintainer: | Jagadish Ramasamy <iamjagankmr@gmail.com> |
| Repository: | CRAN |
| Date/Publication: | 2025-09-14 16:10:13 UTC |
Diagnosis of Metabolic Dysfunction Associated Fatty Liver Disease
Description
The latest guidelines proposed by International Expert Consensus are used widely for the clinical diagnosis of Metabolic Associated Fatty Liver Disease (MAFLD). The new definition takes hepatic steatosis (determined by elastography or histology or biomarker-based fatty liver index) as a major criterion. In addition, race, gender, body mass index (BMI), waist circumference (WC), fasting plasma glucose (FPG), systolic blood pressure (SBP), diastolic blood pressure (DBP), triglycerides (TG), high-density lipoprotein cholesterol (HDLC), homeostatic model assessment of insulin resistance (HOMAIR), high sensitive c-reactive protein (HsCRP) for the diagnosis of MAFLD. Each parameter has to be interpreted based on the proposed cut-offs, making the diagnosis slightly complex and error-prone. This package is developed by incorporating the latest international expert consensus guidelines, and it will aid in the easy and quick diagnosis of MAFLD based on FibroScan in busy healthcare settings and also for research purposes. The new definition for MAFLD as per the International Consensus Statement is described by Eslam M et al (2020). <doi:10.1016/j.jhep.2020.03.039>.
Usage
MAFLD(x)
Arguments
x |
a data frame with column names as exactly specified. |
Value
Yes or No
Examples
MAFLD(x)
An example data frame
Description
A data frame with exact column names as specified
Usage
x
Format
A data frame with parameters needed to diagnose MAFLD:
- CAP
Controlled Attenuation Parameter in dB/m
- BMI
Body mass index in kg/m2
- Race
either Caucasians or Asians
- Gender
Gender in Male or Female
- WC
Waist Circumference in cm
- FPG
Fasting plasma glucose in mg/dL
- HbA1C
Glycated Hemoglobin (in%)
- SBP
Systolic BP in mm Hg
- DBP
Diastolic BP in mm Hg
- HDL
High Density Lipoprotein Cholesterol in mg/dL
- TG
Triglycerides in mg/dL
- HOMAIR
Homeostatis Model Assessment of Inuslin Resistance
- HSCRP
High Sensitive C reative Protein